Document is current

The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP)

Crossref DOI link: https://doi.org/10.1186/s40463-023-00668-z

Published Online: 2023-01-01

Published Print: 2023-01

Update policy: https://doi.org/10.1177/sage-journals-update-policy